Fallopian Tube Diseases: Clinical Trials

1 trial for Fallopian Tube Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 suspended. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Suspended 1
Phase 21Suspended 1

Follow Fallopian Tube Diseases: new trials by email Literature Review of Fallopian Tube Diseases trials Research Report on Fallopian Tube Diseases

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate Lucitanib in Combination With Nivolumab in Patients With a Solid Tumor
Lucitanib, Nivolumab - Advanced Solid Tumor, Gynecologic Cancer
Phase 1 / Phase 2SuspendedClovis Oncology, Inc.2272019-07-292022-12-20

Narrower conditions

Endometrial Neoplasms (1)  ·  Fallopian Tube Neoplasms (1)  ·  Genital Neoplasms, Female (1)  ·  Ovarian Neoplasms (1)  ·  Uterine Cervical Neoplasms (1)

Broader conditions

Adnexal Diseases (1)  ·  Endocrine Gland Neoplasms (1)  ·  Endocrine System Diseases (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Genital Diseases (1)  ·  Genital Diseases, Female (1)  ·  Gonadal Disorders (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Ovarian Diseases (1)  ·  Urogenital Diseases (1)  ·  Urogenital Neoplasms (1)  ·  Uterine Cervical Diseases (1)

Interventions

E-3810 (1)  ·  Nivolumab (1)

Sponsors

Clovis Oncology, Inc. (1)

Countries

Austria (1)  ·  Belgium (1)  ·  Germany (1)  ·  Italy (1)  ·  Spain (1)  ·  United States (1)

Top investigators

Erika Hamilton, MD (1)  ·  Nicole Concin, MD (1)